Skip to main content
Signal8

PMGC Holdings Inc. (PMGC) Form 8-K — Nov 5, 2026

$PMGCForm 8-KItems 1.01, 7.01, 9.01Filed Nov 5, 2026, 4:00 PM ET0001213900-26-116357Original filing

PMGC Holdings (ELAB) entered two paid marketing agreements: a $300,000 three-month consulting deal with IR Agency LLC starting November 10, 2026, and a one-month C$185,000 digital marketing agreement with Senergy Communications Capital, both aimed at investor awareness and media distribution. The IR Agency fees are strictly non-refundable, and the company signaled it may sign additional similar consultancy agreements. Separately, the company announced results from its EL-32 preclinical combination study with semaglutide via its subsidiary NorthStrive Biosciences.

Key figures

Senergy fee cad
185000
Ir agency fee usd
300000
Study duration weeks
8

AI analysis

Red flags3 · Pro

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.